Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Nervous System Diseases"" wg kryterium: Temat


Tytuł :
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
Autorzy :
Sharifian-Dorche M; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Huot P; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Osherov M; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Wen D; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Saveriano A; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Giacomini PS; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Antel JP; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Mowla A; Department of Neurological Surgery, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2020 Oct 15; Vol. 417, pp. 117085. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji :
Comparative Study; Journal Article; Review
MeSH Terms :
Betacoronavirus*
Pandemics*
Coronavirus Infections/*complications
Nervous System Diseases/*etiology
Pneumonia, Viral/*complications
COVID-19 ; Consciousness Disorders/etiology ; Cranial Nerve Diseases/etiology ; Encephalitis, Viral/etiology ; Humans ; Magnetic Resonance Imaging ; Muscular Diseases/etiology ; Neuroimaging ; Peripheral Nervous System Diseases/etiology ; SARS-CoV-2 ; Seizures/etiology ; Severe Acute Respiratory Syndrome/complications ; Stroke/etiology
Czasopismo naukowe
Tytuł :
Neurological Manifestations of SARS-CoV-2: A Narrative Review.
Autorzy :
Khan AR; Dow Medical College, Dow University of Health Sciences (DUHS).
Farooqui MO; Dow Medical College, Dow University of Health Sciences (DUHS).
Jatoi NN; Dow Medical College, Dow University of Health Sciences (DUHS).
Jawaid S; Dow Medical College, Dow University of Health Sciences (DUHS).
Mahdi D; Internal Medicine, Ziauddin University, Karachi, Pakistan.
Khosa F; Radiology Department, Vancouver General Hospital, University of British Columbia, Vancouver, BC.
Pokaż więcej
Źródło :
The neurologist [Neurologist] 2020 Dec 30; Vol. 26 (1), pp. 15-19. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*complications
Central Nervous System Diseases/*etiology
Musculoskeletal Diseases/*etiology
Peripheral Nervous System Diseases/*etiology
Central Nervous System Diseases/diagnostic imaging ; Central Nervous System Diseases/physiopathology ; Humans ; Musculoskeletal Diseases/diagnostic imaging ; Musculoskeletal Diseases/physiopathology ; Peripheral Nervous System Diseases/diagnostic imaging ; Peripheral Nervous System Diseases/physiopathology
Czasopismo naukowe
Tytuł :
Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms.
Autorzy :
Neumann B; Department of Neurology, University of Regensburg, Bezirksklinikum, Regensburg, Germany. Electronic address: .
Schmidbauer ML; Department of Neurology, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU), Munich, Germany. Electronic address: .
Dimitriadis K; Department of Neurology, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU), Munich, Germany; Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU), Munich, Germany. Electronic address: .
Otto S; Department of Neurology, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU), Munich, Germany. Electronic address: .
Knier B; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich Germany, Germany. Electronic address: .
Niesen WD; Department of Neurology and Neurophysiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany. Electronic address: .
Hosp JA; Department of Neurology and Neurophysiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany. Electronic address: .
Günther A; Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany. Electronic address: .
Lindemann S; Department of Neurology, SRH Wald-Klinikum Gera GmbH, Gera, Germany. Electronic address: .
Nagy G; Department of Neurology, Klinikum Kassel, Kassel, Germany. Electronic address: .
Steinberg T; Department of Neurology, University of Regensburg, Bezirksklinikum, Regensburg, Germany. Electronic address: .
Linker RA; Department of Neurology, University of Regensburg, Bezirksklinikum, Regensburg, Germany. Electronic address: .
Hemmer B; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich Germany, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Electronic address: .
Bösel J; Department of Neurology, Klinikum Kassel, Kassel, Germany. Electronic address: .
Pokaż więcej
Corporate Authors :
PANDEMIC and the IGNITE study groups
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2020 Nov 15; Vol. 418, pp. 117090. Date of Electronic Publication: 2020 Aug 11.
Typ publikacji :
Letter; Observational Study
MeSH Terms :
COVID-19/*cerebrospinal fluid
COVID-19/*virology
Nervous System Diseases/*cerebrospinal fluid
Nervous System Diseases/*virology
Adult ; Aged ; Aged, 80 and over ; COVID-19/complications ; Female ; Humans ; Male ; Middle Aged ; Nervous System Diseases/complications ; Nervous System Diseases/diagnosis ; Pandemics ; Polymerase Chain Reaction ; RNA, Viral/cerebrospinal fluid ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification
Raport
Tytuł :
Neurological issues during COVID-19: An overview.
Autorzy :
Nath A; Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States. Electronic address: .
Smith B; Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Pokaż więcej
Źródło :
Neuroscience letters [Neurosci Lett] 2021 Jan 18; Vol. 742, pp. 135533. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Review
MeSH Terms :
Brain/*pathology
COVID-19/*complications
COVID-19/*pathology
Nervous System Diseases/*etiology
Nervous System Diseases/*pathology
COVID-19/metabolism ; Humans ; Nervous System Diseases/metabolism
Czasopismo naukowe
Tytuł :
Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19).
Autorzy :
Gold DM; NYU Langone Medical Center, Department of Neurology, 222 E. 41(st) St., New York, NY, 10017, USA. Electronic address: .
Galetta SL; NYU Langone Medical Center, Departments of Neurology and Ophthalmology, 222 E. 41(st) St., New York, NY, 10017, USA. Electronic address: .
Pokaż więcej
Źródło :
Neuroscience letters [Neurosci Lett] 2021 Jan 18; Vol. 742, pp. 135531. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*complications
Cytokine Release Syndrome/*etiology
Nervous System Diseases/*etiology
Vision Disorders/*etiology
COVID-19/diagnosis ; COVID-19/metabolism ; Cytokine Release Syndrome/diagnosis ; Cytokine Release Syndrome/metabolism ; Humans ; Nervous System Diseases/diagnosis ; Nervous System Diseases/metabolism ; Vision Disorders/diagnosis ; Vision Disorders/metabolism
Czasopismo naukowe
Tytuł :
Mesenchymal stem cells reduce the oxaliplatin-induced sensory neuropathy through the reestablishment of redox homeostasis in the spinal cord.
Autorzy :
Dos Santos GGL; Gonçalo Moniz Institute, Oswaldo Cruz Foundation-FIOCRUZ, 40296-710 Salvador, BA, Brazil.
Oliveira ALL; Gonçalo Moniz Institute, Oswaldo Cruz Foundation-FIOCRUZ, 40296-710 Salvador, BA, Brazil.
Santos DS; College of Pharmacy, Federal University of Bahia, 40170-115 Salvador, BA, Brazil.
do Espírito Santo RF; Gonçalo Moniz Institute, Oswaldo Cruz Foundation-FIOCRUZ, 40296-710 Salvador, BA, Brazil.
Silva DN; SENAI Institute of Innovation in Advanced Health Systems (ISI SAS), University Center SENAI/CIMATEC, 41650-010 Salvador, Bahia, Brazil.
Juiz PJL; Federal University of Recôncavo of Bahia, 44042-280 Feira de Santana, BA, Brazil.
Soares MBP; Gonçalo Moniz Institute, Oswaldo Cruz Foundation-FIOCRUZ, 40296-710 Salvador, BA, Brazil; SENAI Institute of Innovation in Advanced Health Systems (ISI SAS), University Center SENAI/CIMATEC, 41650-010 Salvador, Bahia, Brazil.
Villarreal CF; Gonçalo Moniz Institute, Oswaldo Cruz Foundation-FIOCRUZ, 40296-710 Salvador, BA, Brazil; College of Pharmacy, Federal University of Bahia, 40170-115 Salvador, BA, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Jan 15; Vol. 265, pp. 118755. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article
MeSH Terms :
Mesenchymal Stem Cell Transplantation*
Oxidation-Reduction*/drug effects
Oxaliplatin/*toxicity
Peripheral Nervous System Diseases/*chemically induced
Sensory Receptor Cells/*drug effects
Spinal Cord/*drug effects
Animals ; Interleukin-1beta/metabolism ; Male ; Mesenchymal Stem Cells/metabolism ; Mesenchymal Stem Cells/physiology ; Mice ; Mice, Inbred C57BL ; Nociception ; Peripheral Nervous System Diseases/metabolism ; Peripheral Nervous System Diseases/therapy ; Real-Time Polymerase Chain Reaction ; Rotarod Performance Test ; Sensory Receptor Cells/metabolism ; Sensory Receptor Cells/physiology ; Spinal Cord/metabolism ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
Autorzy :
Edén A; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Kanberg N; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Gostner J; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Fuchs D; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Hagberg L; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Andersson LM; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Lindh M; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Price RW; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Zetterberg H; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London.
Gisslén M; From the Department of Infectious Diseases (A.E., N.K., L.H., L.-M.A., M.L., M.G.), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Region Västra Götaland (A.E., N.K., L.H., L.-M.A., M.G.), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden; Institutes of Medical Biochemistry (J.G.) and Biological Chemistry (D.F.), Medical University of Innsbruck, Biocenter, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience & Physiology, Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z.), UCL Institute of Neurology; and UK Dementia Research Institute at UCL (H.Z.), London. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2021 Jan 12; Vol. 96 (2), pp. e294-e300. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
COVID-19/*cerebrospinal fluid
COVID-19/*complications
Nervous System Diseases/*cerebrospinal fluid
Nervous System Diseases/*etiology
SARS-CoV-2/*isolation & purification
Adult ; Aged ; Aged, 80 and over ; Biomarkers/cerebrospinal fluid ; Blood-Brain Barrier/diagnostic imaging ; Blood-Brain Barrier/metabolism ; COVID-19/diagnostic imaging ; Female ; Humans ; Male ; Middle Aged ; Nervous System Diseases/diagnostic imaging
Czasopismo naukowe
Tytuł :
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
Autorzy :
Ong WY; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119260, Singapore. .; Neurobiology Programme, Life Sciences Institute, National University of Singapore, Singapore, 119260, Singapore. .
Go ML; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, 119260, Singapore.
Wang DY; Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119260, Singapore.
Cheah IK; Neurobiology Programme, Life Sciences Institute, National University of Singapore, Singapore, 119260, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119260, Singapore.
Halliwell B; Neurobiology Programme, Life Sciences Institute, National University of Singapore, Singapore, 119260, Singapore. .; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119260, Singapore. .
Pokaż więcej
Źródło :
Molecular neurobiology [Mol Neurobiol] 2021 Jan; Vol. 58 (1), pp. 106-117. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
SARS-CoV-2*
Antimalarials/*therapeutic use
COVID-19/*complications
COVID-19/*drug therapy
Nervous System Diseases/*drug therapy
Nervous System Diseases/*etiology
Animals ; Antimalarials/metabolism ; Blood-Brain Barrier/drug effects ; Blood-Brain Barrier/metabolism ; COVID-19/metabolism ; Humans ; Nervous System Diseases/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The Relationship Between Autonomic Dysfunction of the Gastrointestinal Tract and Emotional Distress in Patients With Systemic Sclerosis.
Autorzy :
DiRenzo D; From the Division of Rheumatology, Johns Hopkins University School of Medicine.
Russell J; Department of Neurology, University of Maryland, Baltimore, MD.
Bingham CO 3rd; From the Division of Rheumatology, Johns Hopkins University School of Medicine.
McMahan Z; From the Division of Rheumatology, Johns Hopkins University School of Medicine.
Pokaż więcej
Źródło :
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2021 Jan 01; Vol. 27 (1), pp. 11-17.
Typ publikacji :
Journal Article
MeSH Terms :
Autonomic Nervous System Diseases*/diagnosis
Autonomic Nervous System Diseases*/etiology
Autonomic Nervous System Diseases*/physiopathology
Gastrointestinal Diseases*/diagnosis
Gastrointestinal Diseases*/etiology
Gastrointestinal Diseases*/psychology
Psychological Distress*
Scleroderma, Systemic*/blood
Scleroderma, Systemic*/epidemiology
Scleroderma, Systemic*/physiopathology
Scleroderma, Systemic*/psychology
Autoantibodies/blood ; Autonomic Nervous System/physiopathology ; Exoribonucleases/immunology ; Exosome Multienzyme Ribonuclease Complex/immunology ; Female ; Gastrointestinal Tract/innervation ; Humans ; Male ; Middle Aged ; Research Design ; Severity of Illness Index ; Symptom Assessment/methods ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Coronavirus 2019: clinical and neuropathological aspects.
Autorzy :
Younger DS; City University of New York, Medical School, Neuroscience Division, New York, New York, USA.
Pokaż więcej
Źródło :
Current opinion in rheumatology [Curr Opin Rheumatol] 2021 Jan; Vol. 33 (1), pp. 49-57.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Pandemics*
COVID-19/*diagnosis
Nervous System Diseases/*diagnosis
COVID-19/complications ; COVID-19/epidemiology ; Global Health ; Humans ; Incidence ; Nervous System Diseases/epidemiology ; Nervous System Diseases/etiology
Czasopismo naukowe
Tytuł :
Chronic kidney disease as a risk factor for peripheral nerve impairment in older adults: A longitudinal analysis of Health, Aging and Body Composition (Health ABC) study.
Autorzy :
Doshi S; Division of Nephrology, Indiana University, Indianapolis, IN, United States of America.
Moorthi RN; Division of Nephrology, Indiana University, Indianapolis, IN, United States of America.
Fried LF; University of Pittsburgh, Pittsburgh, PA, United States of America.
Sarnak MJ; Tufts Medical Center, Boston, MA, United States of America.
Satterfield S; University of Tennessee, Memphis, TN, United States of America.
Shlipak M; University of California, San Francisco, CA, United States of America.
Lange-Maia BS; Rush University Medical Center, Chicago, IL, United States of America.
Newman AB; University of Pittsburgh, Pittsburgh, PA, United States of America.
Strotmeyer ES; University of Pittsburgh, Pittsburgh, PA, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Dec 15; Vol. 15 (12), pp. e0242406. Date of Electronic Publication: 2020 Dec 15 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Peripheral Nerves/*physiopathology
Peripheral Nervous System Diseases/*epidemiology
Renal Insufficiency, Chronic/*epidemiology
Aged ; Aging ; European Continental Ancestry Group ; Female ; Follow-Up Studies ; Humans ; Longitudinal Studies ; Male ; Neural Conduction/physiology ; Peripheral Nervous System Diseases/diagnosis ; Peripheral Nervous System Diseases/etiology ; Peripheral Nervous System Diseases/physiopathology ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/physiopathology ; Risk Factors ; Self Report/statistics & numerical data ; Sensory Thresholds/physiology
Czasopismo naukowe
Tytuł :
Presentations and mechanisms of CNS disorders related to COVID-19.
Autorzy :
Bodro M; From the Infectious Diseases Department (M.B.), Hospital Clínic de Barcelona, Catalonia; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (M.B., Y.C., R.S.-V.), Barcelona; Department of Medicine (M.B., Y.C., R.S.-V.), Universitat de Barcelona; Neurology Department (Y.C., R.S.-V.), Hospital Clínic de Barcelona; and Institut de Neurociències (Y.C., R.S.-V.), Maria de Maeztu Excellence Center, Universitat de Barcelona, Catalonia, Spain.
Compta Y; From the Infectious Diseases Department (M.B.), Hospital Clínic de Barcelona, Catalonia; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (M.B., Y.C., R.S.-V.), Barcelona; Department of Medicine (M.B., Y.C., R.S.-V.), Universitat de Barcelona; Neurology Department (Y.C., R.S.-V.), Hospital Clínic de Barcelona; and Institut de Neurociències (Y.C., R.S.-V.), Maria de Maeztu Excellence Center, Universitat de Barcelona, Catalonia, Spain. .
Sánchez-Valle R; From the Infectious Diseases Department (M.B.), Hospital Clínic de Barcelona, Catalonia; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (M.B., Y.C., R.S.-V.), Barcelona; Department of Medicine (M.B., Y.C., R.S.-V.), Universitat de Barcelona; Neurology Department (Y.C., R.S.-V.), Hospital Clínic de Barcelona; and Institut de Neurociències (Y.C., R.S.-V.), Maria de Maeztu Excellence Center, Universitat de Barcelona, Catalonia, Spain.
Pokaż więcej
Źródło :
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2020 Dec 11; Vol. 8 (1). Date of Electronic Publication: 2020 Dec 11 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
MeSH Terms :
Brain/*metabolism
Brain/*pathology
COVID-19/*complications
COVID-19/*metabolism
Central Nervous System Diseases/*etiology
Central Nervous System Diseases/*metabolism
Brain/immunology ; COVID-19/immunology ; Central Nervous System Diseases/immunology ; Humans ; Inflammation Mediators/immunology ; Inflammation Mediators/metabolism
Czasopismo naukowe
Tytuł :
Self-Reported Disability in Persons With HIV-Related Neuropathy Is Mediated by Pain Interference and Depression.
Autorzy :
Kietrys DM; Department of Rehabilitation and Movement Sciences, School of Health Professions, Rutgers, The State University of New Jersey, 200 College Dr, Jefferson Hall #308, Blackwood, NJ 08012 (USA).
Parrott JS; Department of Interdisciplinary Studies, School of Health Professions, Rutgers, The State University of New Jersey.
Galantino ML; Physical Therapy Program, School of Health Sciences, Stockton University, Galloway, New Jersey; Family Medicine and Community Health, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania; and University of Witwatersrand, Johannesburg, South Africa.
Davis T; Department of Interdisciplinary Studies, School of Health Professions, Rutgers, The State University of New Jersey.
Levin T; School of Osteopathic Medicine, Rowan University, Stratford, New Jersey; and Jefferson Health, Voorhees, New Jersey.
O'Brien KK; Department of Physical Therapy, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto; and Rehabilitation Sciences Institute, University of Toronto.
Pokaż więcej
Źródło :
Physical therapy [Phys Ther] 2020 Dec 07; Vol. 100 (12), pp. 2174-2185.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Self Report*
Depression/*complications
HIV Infections/*complications
Pain/*complications
Peripheral Nervous System Diseases/*etiology
Cross-Sectional Studies ; Depression/psychology ; Disability Evaluation ; Female ; Health Surveys ; Humans ; Hypesthesia/diagnosis ; Hypesthesia/etiology ; Lower Extremity ; Male ; Middle Aged ; Pain Measurement/methods ; Paresthesia/diagnosis ; Paresthesia/etiology ; Peripheral Nervous System Diseases/complications ; Peripheral Nervous System Diseases/diagnosis ; Regression Analysis
SCR Disease Name :
Neuropathy, Painful
Czasopismo naukowe
Tytuł :
What Does Neuroscience Tell Us About the Conversion Model of Functional Neurological Disorders?
Autorzy :
Cretton A; The Department of Neurology, University Hospital Bern and University of Bern, Bern, Switzerland (Cretton, Aybek); the School of Health Sciences, University of Manchester, Manchester, United Kingdom (Brown); Manchester Academic Health Sciences Centre, Greater Manchester Mental Health National Health Service Foundation Trust, Manchester, United Kingdom (Brown); and the Departments of Psychiatry and Neurology, Rhode Island Hospital, Brown University, Providence, R.I. (LaFrance).
Brown RJ; The Department of Neurology, University Hospital Bern and University of Bern, Bern, Switzerland (Cretton, Aybek); the School of Health Sciences, University of Manchester, Manchester, United Kingdom (Brown); Manchester Academic Health Sciences Centre, Greater Manchester Mental Health National Health Service Foundation Trust, Manchester, United Kingdom (Brown); and the Departments of Psychiatry and Neurology, Rhode Island Hospital, Brown University, Providence, R.I. (LaFrance).
LaFrance WC Jr; The Department of Neurology, University Hospital Bern and University of Bern, Bern, Switzerland (Cretton, Aybek); the School of Health Sciences, University of Manchester, Manchester, United Kingdom (Brown); Manchester Academic Health Sciences Centre, Greater Manchester Mental Health National Health Service Foundation Trust, Manchester, United Kingdom (Brown); and the Departments of Psychiatry and Neurology, Rhode Island Hospital, Brown University, Providence, R.I. (LaFrance).
Aybek S; The Department of Neurology, University Hospital Bern and University of Bern, Bern, Switzerland (Cretton, Aybek); the School of Health Sciences, University of Manchester, Manchester, United Kingdom (Brown); Manchester Academic Health Sciences Centre, Greater Manchester Mental Health National Health Service Foundation Trust, Manchester, United Kingdom (Brown); and the Departments of Psychiatry and Neurology, Rhode Island Hospital, Brown University, Providence, R.I. (LaFrance).
Pokaż więcej
Źródło :
The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] 2020 Winter; Vol. 32 (1), pp. 24-32. Date of Electronic Publication: 2019 Oct 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Conversion Disorder*/etiology
Conversion Disorder*/physiopathology
Conversion Disorder*/psychology
Nervous System Diseases*/etiology
Nervous System Diseases*/physiopathology
Nervous System Diseases*/psychology
Psychophysiologic Disorders*/etiology
Psychophysiologic Disorders*/physiopathology
Psychophysiologic Disorders*/psychology
Humans
Czasopismo naukowe
Tytuł :
Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities.
Autorzy :
Nicholson TR; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Carson A; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Edwards MJ; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Goldstein LH; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Hallett M; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Mildon B; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Nielsen G; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Nicholson C; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Perez DL; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Pick S; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Stone J; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
Pokaż więcej
Corporate Authors :
and the FND-COM (Functional Neurological Disorders Core Outcome Measures) Group; The Institute of Psychiatry, Psychology and Neuroscience, King's College London (T. Nicholson, Goldstein, Pick); the Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (Carson, Stone); the Department of Rehabilitation Medicine, Astley Ainslie Hospital, Edinburgh, United Kingdom (Carson); the Neuroscience Research Centre, St. George's University of London (Edwards, Nielsen); Human Motor Control Section, the National Institute of Neurological Disorders and Stroke, Bethesda, Md. (Hallett); FND Hope International, Banbury, United Kingdom (Mildon); the National Hospital for Neurology and Neurosurgery, University College London, and Hospitals National Health Service Foundation Trust, London (C. Nicholson); and the Departments of Neurology and Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Perez).
FND-COM group collaborators are as follows
Źródło :
The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] 2020 Winter; Vol. 32 (1), pp. 33-42. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Conversion Disorder*/diagnosis
Conversion Disorder*/physiopathology
Nervous System Diseases*/diagnosis
Nervous System Diseases*/physiopathology
Outcome Assessment, Health Care*
Psychophysiologic Disorders*/diagnosis
Psychophysiologic Disorders*/physiopathology
Humans
Czasopismo naukowe
Tytuł :
Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
Autorzy :
Bonhof CS; CoRPS - Center of Research on Psychology in Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University, PO Box 90153, 5000, LE, Tilburg, the Netherlands. .; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. .
Trompetter HR; CoRPS - Center of Research on Psychology in Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University, PO Box 90153, 5000, LE, Tilburg, the Netherlands.
Vreugdenhil G; Department of Internal Medicine, Máxima Medical Centre, Eindhoven and Veldhoven, The Netherlands.
van de Poll-Franse LV; CoRPS - Center of Research on Psychology in Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University, PO Box 90153, 5000, LE, Tilburg, the Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Mols F; CoRPS - Center of Research on Psychology in Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University, PO Box 90153, 5000, LE, Tilburg, the Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Dec; Vol. 28 (12), pp. 5933-5941. Date of Electronic Publication: 2020 Apr 12.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*adverse effects
Cancer Survivors/*psychology
Colonic Neoplasms/*psychology
Peripheral Nervous System Diseases/*epidemiology
Quality of Life/*psychology
Aged ; Antineoplastic Agents/therapeutic use ; Anxiety/psychology ; Colonic Neoplasms/drug therapy ; Female ; Humans ; Hypesthesia/chemically induced ; Hypesthesia/psychology ; Male ; Middle Aged ; Netherlands/epidemiology ; Pain/drug therapy ; Pain/psychology ; Paresthesia/chemically induced ; Paresthesia/psychology ; Peripheral Nervous System Diseases/chemically induced ; Peripheral Nervous System Diseases/psychology ; Registries ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
Autorzy :
Fujieda Y; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Pokaż więcej
Źródło :
Immunological medicine [Immunol Med] 2020 Dec; Vol. 43 (4), pp. 135-141. Date of Electronic Publication: 2020 May 27.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Lupus Erythematosus, Systemic/*complications
Lupus Erythematosus, Systemic/*immunology
Mental Disorders/*etiology
Nervous System Diseases/*etiology
Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/therapeutic use ; Antibodies, Antinuclear ; Autoantibodies ; Cytokines/cerebrospinal fluid ; Humans ; Hydroxychloroquine/therapeutic use ; Immunoglobulins, Intravenous/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Lupus Erythematosus, Systemic/drug therapy ; Mental Disorders/drug therapy ; Mental Disorders/immunology ; Mycophenolic Acid/therapeutic use ; Nervous System Diseases/drug therapy ; Nervous System Diseases/immunology ; Rituximab/therapeutic use
Czasopismo naukowe
Tytuł :
Letter to the Editor: "What Are the Long-Term Neurological and Neuropsychiatric Consequences of COVID-19?"
Autorzy :
Pan Y; Department of Hand and Foot Surgery, The Affiliated Hospital of QingDao University, Qingdao, China.
Zhao S; Department of Anesthesiology, The First Hospital of Jilin University, Changchun, China.
Chen F; Department of Neurosurgery, The Affiliated Hospital of QingDao University, Qingdao, China. Electronic address: .
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2020 Dec; Vol. 144, pp. 310-311.
Typ publikacji :
Letter
MeSH Terms :
Inflammation Mediators*/blood
Inflammation Mediators*/immunology
SARS-CoV-2*
COVID-19/*complications
Mental Disorders/*etiology
Nervous System Diseases/*etiology
COVID-19/blood ; COVID-19/immunology ; Mental Disorders/blood ; Mental Disorders/immunology ; Nervous System Diseases/blood ; Nervous System Diseases/immunology ; Time Factors
Opinia redakcyjna
Tytuł :
Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study.
Autorzy :
Stone J; The Centre for Clinical Brain Sciences, University of Edinburgh, Royal Infirmary, Edinburgh, United Kingdom (Stone, Warlow); the Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, United Kingdom (Deary); the Department of Psychological Medicine Research, University of Oxford, United Kingdom (Sharpe).
Warlow C; The Centre for Clinical Brain Sciences, University of Edinburgh, Royal Infirmary, Edinburgh, United Kingdom (Stone, Warlow); the Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, United Kingdom (Deary); the Department of Psychological Medicine Research, University of Oxford, United Kingdom (Sharpe).
Deary I; The Centre for Clinical Brain Sciences, University of Edinburgh, Royal Infirmary, Edinburgh, United Kingdom (Stone, Warlow); the Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, United Kingdom (Deary); the Department of Psychological Medicine Research, University of Oxford, United Kingdom (Sharpe).
Sharpe M; The Centre for Clinical Brain Sciences, University of Edinburgh, Royal Infirmary, Edinburgh, United Kingdom (Stone, Warlow); the Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, United Kingdom (Deary); the Department of Psychological Medicine Research, University of Oxford, United Kingdom (Sharpe).
Pokaż więcej
Źródło :
The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] 2020 Winter; Vol. 32 (1), pp. 50-57. Date of Electronic Publication: 2019 Aug 30.
Typ publikacji :
Journal Article
MeSH Terms :
Adult Survivors of Child Abuse*/statistics & numerical data
Adverse Childhood Experiences*/statistics & numerical data
Conversion Disorder*/epidemiology
Conversion Disorder*/physiopathology
Extremities*/physiopathology
Nervous System Diseases*/epidemiology
Nervous System Diseases*/physiopathology
Personality*/physiology
Adolescent ; Adult ; Aged ; Case-Control Studies ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
A biobank in Sri Lanka that links East and West.
Autorzy :
Wijekoon N; Interdisciplinary Centre for Innovation in Biotechnology and Neuroscience, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka.
Gonawala L; Interdisciplinary Centre for Innovation in Biotechnology and Neuroscience, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka.
Wijesinghe P; Interdisciplinary Centre for Innovation in Biotechnology and Neuroscience, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka; European Graduate School of Neuroscience, Maastricht University, Maastricht, The Netherlands.
Steinbusch HW; European Graduate School of Neuroscience, Maastricht University, Maastricht, The Netherlands; Department of Translational Neuroscience, Faculty Health, Medicine & Life Sciences, Maastricht University, Maastricht, The Netherlands.
Mohan C; Department of Bioengineering, University of Houston, Houston, TX, USA.
de Silva KRD; Interdisciplinary Centre for Innovation in Biotechnology and Neuroscience, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka; European Graduate School of Neuroscience, Maastricht University, Maastricht, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Neurology [Lancet Neurol] 2020 Dec; Vol. 19 (12), pp. 972.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Biological Specimen Banks*/organization & administration
Biological Specimen Banks*/statistics & numerical data
Biotechnology*/organization & administration
Biotechnology*/statistics & numerical data
Nervous System Diseases*/diagnosis
Nervous System Diseases*/genetics
Neurosciences*/organization & administration
Neurosciences*/statistics & numerical data
Academic Medical Centers/organization & administration ; Academic Medical Centers/statistics & numerical data ; Humans ; Sri Lanka
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies